This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Celgene Corporation. Active years: 2025.
Company Filing History:
1 out of 3,737 
1 out of 561 
Years Active: 2025
Title: The Innovative Contributions of Natalie Holmberg-Douglas
Introduction
Natalie Holmberg-Douglas is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of compounds for medical applications. Her work focuses on addressing critical health issues, including cancer and autoimmune diseases.
Latest Patents
Holmberg-Douglas holds a patent for "Modulators of BCL6 as ligand directed degraders." This patent provides compounds and compositions designed to modulate BCL6, which plays a crucial role in various diseases. The innovative compounds she developed are aimed at treating cancer and autoimmune diseases, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Natalie has worked with notable companies in the pharmaceutical industry. She has been associated with Celgene Corporation and Bristol-Myers Squibb Company, where she contributed her expertise in drug development and research. Her experience in these leading organizations has helped her refine her skills and expand her impact in the field.
Collaborations
Holmberg-Douglas has collaborated with esteemed colleagues, including Dehua Huang and Matthew David Alexander. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Natalie Holmberg-Douglas is a trailblazer in the field of biotechnology, with a focus on developing innovative solutions for serious health challenges. Her patent and collaborations reflect her dedication to improving patient outcomes through scientific advancement.